Results 11 to 20 of about 242,514 (346)
Insulin-Based Infusion System: Advancing the Development [PDF]
Journal of Diabetes Science and Technology, 2019 Background: Deviations in glucose control in critical care have been shown to increase mortality and morbidity. However, optimal glucose control through present technologies has shown to be a challenge. The insulin balanced infusion system (IBIS) is a new and emerging technology.
Nasseh Hashemi +3 more
openaire +4 more sources
AACE Clinical Case Reports, 2023 Background/Objective Closed-loop insulin infusion systems (CLSs) such as Tandem t:slim with Control-IQ (t:slim CIQ) improve glycemic control and decrease diabetic ketoacidosis (DKA) risk in type 1 diabetes mellitus (T1DM). We report a case of CLS failure,
Pranjal Sharma +2 more
semanticscholar +1 more source
Insulin pump therapy in transient neonatal diabetes mellitus [PDF]
Annals of Pediatric Endocrinology & Metabolism, 2013 Neonatal diabetes mellitus (NDM) is a rare disease requiring insulin treatment. Its treatment is primarily focused on maintaining adequate glycemic control and avoiding hypoglycemia.
Joong Heum Park +6 more
doaj +1 more source
Symposium 16: Clinical follow-up: new guidelines and consensus
Revista de la Sociedad Argentina de Diabetes, 2022 Immune-mediated diabetes in adults is a challenge in its diagnosis, as well as its differentiation from type 2 diabetes and LADA. In the follow-up and treatment of this population, an intensified insulin therapy is the ideal regimen of insulin ...
Susana Apoloni
doaj +1 more source
Best Achievements in Clinical Medicine in Diabetes and Dyslipidemia in 2020 [PDF]
Endocrinology and Metabolism, 2021 Over the last two decades, our understanding of diabetes and treatment strategies have evolved tremendously, from scientific, mechanistic, and human perspectives.
Eun-Jung Rhee +2 more
doaj +1 more source
Insulin hypoglycaemia test guided by a glucose controlled insulin infusion system [PDF]
Acta Endocrinologica, 1984 Abstract. Insulin hypoglycaemia test (IHT) for assessment of hypothalamic-pituitary-adrenocortical (HPA) function in patients with pituitary tumours is usually performed by bolus injection of insulin, a procedure which includes the risk of overdosage and/or the need of repeated administration.
Müller-Esch, G. +4 more
openaire +3 more sources
Вопросы современной педиатрии, 2020 Background. Dermatological complications of insulin therapy in children with type 1 diabetes (T1D) cause low patient retention to treatment, reduce insulin therapy (with injection pens and pumps) efficiency, limit the use of modern high-tech methods of ...
Alisa V. Vitebskaya +2 more
doaj +1 more source
Dynamic Insulin Basal Needs Estimation and Parameters Adjustment in Type 1 Diabetes
Sensors, 2021 Technology advances have made possible improvements such as Continuous Glucose Monitors, giving the patient a glucose reading every few minutes, or insulin pumps, allowing more personalized therapies.
Jesús Berián +4 more
doaj +1 more source
Improving the clinical value and utility of CGM systems: issues and recommendations : a joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group [PDF]
, 2017 The first systems for continuous glucose monitoring (CGM) became available over 15 years ago. Many then believed CGM would revolutionise the use of intensive insulin therapy in diabetes; however, progress towards that vision has been gradual.
Bergenstal, Richard M. +5 more
core +4 more sources
Mast Cell Deficiency in Mice Attenuates Insulin Phenolic Preservative-Induced Inflammation
Biomedicines, 2023 One major obstacle that limits the lifespan of insulin infusion pumps is surmounting the tissue site reaction at the device implantation site. All commercial insulin formulations contain insulin phenolic preservatives (IPPs) designed to ensure insulin ...
Shereen Kesserwan +3 more
doaj +1 more source